Evidence map

ArticleClinical epigenetics2026

Promoter hypomethylation drives ABCB1-mediated carfilzomib resistance in multiple myeloma.

Seungbin Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41923105